Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(61,059 products)
Found 199580 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Bromo-2,3-dihydro-1H-pyrrolizine-7-carbonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H7BrN2Purity:Min. 95%Molecular weight:211.06 g/molMethyl 2-bromo-6-fluoro-4-(trifluoromethyl)benzoate
CAS:Versatile small molecule scaffoldFormula:C9H5BrF4O2Purity:Min. 95%Molecular weight:301.03 g/molMethyl 1-aminoisoquinoline-4-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H10N2O2Purity:Min. 95%Molecular weight:202.21 g/mol8-Bromo-3-nitroquinolin-4-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H5BrN2O3Purity:Min. 95%Molecular weight:269.05 g/molN-{4-[1-(Hydroxyamino)ethylidene]cyclohexa-2,5-dien-1-ylidene}methanesulfonamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H12N2O3SPurity:Min. 95%Molecular weight:228.27 g/mol3-Fluoro-N,4-dimethylbenzamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H10FNOPurity:Min. 95%Molecular weight:167.18 g/mol1-(4-Methylpiperazin-1-yl)-3-(methylsulfanyl)propan-1-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H18N2OSPurity:Min. 95%Molecular weight:202.3 g/mol2-Chloro-4-(4-fluorophenoxy)pyrimidine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H6ClFN2OPurity:Min. 95%Molecular weight:224.62 g/mol1-(2-Hydroxyethyl)-5-nitro-1,2-dihydropyridin-2-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H8N2O4Purity:Min. 95%Molecular weight:184.15 g/mol2-(2,3-Dihydro-1H-inden-5-yl)acetamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H13NOPurity:Min. 95%Molecular weight:175.23 g/mol1-(3-Chlorophenyl)cyclopropane-1-carboxamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H10ClNOPurity:Min. 95%Molecular weight:195.64 g/mol2-[Cyclopentyl(methyl)amino]acetamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H16N2OPurity:Min. 95%Molecular weight:156.23 g/mol2-Oxo-1,2,3,4-tetrahydroquinoline-6-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C9H10N2O3SPurity:Min. 95%Molecular weight:226.25 g/molInsolution rac1 inhibitor II, Z62954982
CAS:Insolution rac1 inhibitor II, Z62954982 is a novel small molecule that selectively inhibits the insulin-induced glucose uptake in cardiomyocytes. Insolution rac1 inhibitor II, Z62954982 has been shown to enhance insulin-stimulated glucose uptake in cultured cardiomyocytes and inhibit myocardial infarct size in mice following coronary artery ligation. The mechanism of Insolution rac1 inhibitor II, Z62954982 action may be due to its ability to block cardiac adenosine receptors and inhibit the uptake of glucose by blocking the cell surface receptor for insulin. Insolution rac1 inhibitor II, Z62954982 also blocks the production of proinflammatory cytokines such as TNF-α and IL-1β. Insolution rac1 inhibitor II, Z62954982 is orally bioavailable and does not require intravenous administration.Formula:C18H25N5O4Purity:Min. 95%Molecular weight:375.4 g/molMethyl 6-Bromo-2-oxo-2,3-dihydro-1H-indole-4-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H8NO3BrPurity:Min. 95%Molecular weight:270.07 g/molMethyl 6-Bromo-1-methyl-1H-indole-4-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H10NO2BrPurity:Min. 95%Molecular weight:268.1 g/mol(4-Methyl-1H-indol-3-yl)methanol
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H11NOPurity:Min. 95%Molecular weight:161.2 g/mol2-(3-Fluoro-4-methoxyphenyl)acetamide
CAS:Versatile small molecule scaffoldFormula:C9H10FNO2Purity:Min. 95%Molecular weight:183.18 g/molN-(6-Butyl-1,3-benzothiazol-2-yl)-3-[(2-cyanoethyl)sulfamoyl]benzamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C21H22N4O3S2Purity:Min. 95%Molecular weight:442.6 g/mol2-Chloro-6-(4-fluorophenoxy)pyridine
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H7ClFNOPurity:Min. 95%Molecular weight:223.63 g/mol2-(3-Ethyl-1H-1,2,4-triazol-5-yl)aniline
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H12N4Purity:Min. 95%Molecular weight:188.23 g/mol1-(2-Fluorophenyl)-3-(prop-2-yn-1-yl)urea
CAS:<p>1-(2-Fluorophenyl)-3-(prop-2-yn-1-yl)urea is a peptide that can be used as a research tool in cell biology, immunology and pharmacology. It has been shown to inhibit the interaction of proteins and receptors by binding to the active site of enzymes. 1-(2-Fluorophenyl)-3-(prop-2-yn-1-yl)urea binds to ion channels and inhibits the flow of ions, which can lead to changes in cellular function.</p>Formula:C10H9FN2OPurity:Min. 95%Molecular weight:192.19 g/mol1-(4-Bromo-2-chlorophenyl)-2,2,2-trifluoroethan-1-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H3BrClF3OPurity:Min. 95%Molecular weight:287.46 g/mol1-Amino-3-(2,2,2-trifluoroethyl)imidazolidin-2-one
CAS:Versatile small molecule scaffoldFormula:C5H8F3N3OPurity:Min. 95%Molecular weight:183.13 g/mol4-Bromo-6-[(4-methoxyphenyl)methoxy]-2-methylpyrimidine
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H13BrN2O2Purity:Min. 95%Molecular weight:309.16 g/mol(4-Chlorophenyl)[4-(trifluoromethoxy)phenyl]methanamine
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H11ClF3NOPurity:Min. 95%Molecular weight:301.69 g/mol2-[(3,3-Dimethylcyclopentyl)amino]pyridine-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C13H18N2O2Purity:Min. 95%Molecular weight:234.3 g/mol4-Bromo-5-fluoro-1H-indazol-3-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H5BrFN3Purity:Min. 95%Molecular weight:230.04 g/mol4-bromo-5-methyl-1h-indazol-3-amine
CAS:Versatile small molecule scaffoldFormula:C8H8BrN3Purity:Min. 95%Molecular weight:226.08 g/mol3-(4-Chlorophenoxy)azetidine hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H10NOCl·HClPurity:Min. 95%Molecular weight:220.1 g/mol3-(4-Fluorobenzoyl)azetidine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C10H11ClFNOPurity:Min. 95%Molecular weight:215.65 g/mol2-(4-Bromophenyl)-2-(pyrrolidin-1-yl)acetic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H14BrNO2Purity:Min. 95%Molecular weight:284.15 g/mol1-(4-(trifluoromethoxy)phenyl)-piperazine hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H14ClF3N2OPurity:Min. 95%Molecular weight:282.69 g/mol(3S)-3-Amino-3-(2-methylphenyl)propanoic acid hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H14ClNO2Purity:Min. 95%Molecular weight:215.67 g/mol(3S)-3-Amino-3-(2-chlorophenyl)propanoic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C9H11Cl2NO2Purity:Min. 95%Molecular weight:236.09 g/mol(1R,4R)-4-(Difluoromethyl)cyclohexanecarboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H12F2O2Purity:Min. 95%Molecular weight:178.18 g/mol6-(Dimethylsulfamoyl)pyridine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H10N2O4SPurity:Min. 95%Molecular weight:230.24 g/mol6-methylpyridazine-4-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C6H6N2O2Purity:Min. 95%Molecular weight:138.12 g/molPotassium trifluoro[(oxetan-3-ylidene)methyl]boranuide
CAS:<p>Versatile small molecule scaffold</p>Formula:C4H5BF3KOPurity:Min. 95%Molecular weight:175.99 g/mol4,5,6,7-Tetrahydro-thiazolo[4,5-c]pyridine dihydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H10Cl2N2SPurity:Min. 95%Molecular weight:213.13 g/molMethyl 3-methyl-5-phenyl-4,5-dihydro-1,2-oxazole-5-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H13NO3Purity:Min. 95%Molecular weight:219.2 g/moltert-Butyl N-[(2-amino-5-bromophenyl)methyl]carbamate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H17BrN2O2Purity:Min. 95%Molecular weight:301.18 g/mol5-(Prop-2-yn-1-yl)imidazolidine-2,4-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H6N2O2Purity:Min. 95%Molecular weight:138.12 g/mol3-(Aminomethyl)-N-methylbenzamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H12N2OPurity:Min. 95%Molecular weight:164.2 g/mol5-Amino-2-methylbenzamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H10N2OPurity:Min. 95%Molecular weight:150.18 g/mol3-Bromo-5-chloro-4-methylbenzoic acid
CAS:3-Bromo-5-chloro-4-methylbenzoic acid is a molecule that has been optimized for the treatment of rheumatoid arthritis. It inhibits a protein kinase that is involved in the synthesis of pro-inflammatory cytokines. This drug has been shown to be effective in treating rheumatoid arthritis by inhibiting the translational and biosynthetic processes that lead to the production of pro-inflammatory cytokines. 3-Bromo-5-chloro-4-methylbenzoic acid has also been shown to inhibit mitogen activated protein kinase (MAPK) activation, which may be due to its ability to inhibit transcriptional activity.Formula:C8H6BrClO2Purity:Min. 95%Molecular weight:249.49 g/mol5-Bromo-2-fluoro-4-methylbenzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H6BrFO2Purity:Min. 95%Molecular weight:233.03 g/mol3-Bromo-4-methylbenzohydrazide
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H9BrN2OPurity:Min. 95%Molecular weight:229.08 g/mol3-[(3-Aminophenyl)methyl]imidazolidine-2,4-dione
CAS:Versatile small molecule scaffoldFormula:C10H11N3O2Purity:Min. 95%Molecular weight:205.21 g/mol2-Cyclobutanecarbonylpyridine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H11NOPurity:Min. 95%Molecular weight:161.2 g/mol
